Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090675
Status:
WITHDRAWN
Last Update Posted:
2013-01-29
First Post:
2004-09-02
Brief Title:
Maintenance ZD1839 IRESSA Following Completion of Front Line Platinum-Based Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D7913L00019
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None